C85.23
Mediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Mediastinal (thymic) large B-cell lymphoma with intra-abdominal lymph node involvement is a type of non-Hodgkin lymphoma, a cancer that originates in the lymphatic system. This specific subtype involves large B-cells located primarily in the mediastinum—the area in the chest between the lungs—and also affects lymph nodes within the abdomen. Recognizing this disease involves understanding its characteristics, common causes, symptoms, methods of diagnosis, and potential treatment options.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to abnormal B-cell growth Immune system dysfunction or suppression Infections such as Epstein-Barr virus (EBV) or HIV Exposure to certain chemicals or radiation Family history of lymphoma or other hematologic malignancies
Key Symptoms: Swelling or a noticeable lump in the chest area Persistent cough or shortness of breath Unexplained weight loss Fever or night sweats Abdominal pain or swelling Swollen lymph nodes in the abdomen or neck Fatigue or general weakness
Diagnostic & Treatment
Diagnosis Path: The process of diagnosing mediastinal large B-cell lymphoma with abdominal involvement typically includes several steps: - Medical history and physical examination to identify lymph node enlargements or other symptoms. - Imaging tests such as CT scans or PET scans to locate and assess the extent of lymph node or mediastinal masses. - Biopsies, often through fine-needle aspiration or surgical procedures, to examine tissue samples for cancer cell identification. - Laboratory tests, including blood counts and chemistry panels, to evaluate overall health. - Additional tests may include immunophenotyping and molecular studies to confirm the diagnosis and subtype of lymphoma. Early and accurate diagnosis is essential for planning effective treatment strategies.
Treatment Protocols: Treatment options for this type of lymphoma often involve a combination of therapies: - Chemotherapy regimens designed to target and kill cancerous B-cells. - Targeted therapy medications that specifically attack lymphoma cells based on their molecular characteristics. - Radiation therapy in certain cases to reduce tumor size or control localized disease. - Stem cell or bone marrow transplants may be considered, especially after initial therapy failure. - Supportive care, including management of side effects and treatment-related complications, is an integral part of the overall treatment approach. Treatment plans are tailored to the patient's overall health, stage of the disease, and response to initial therapies.
Clinical Advice & FAQs
Billing Guidance
Is C85.23 a billable ICD-10 code?
Yes, C85.23 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C85.23?
Clinical documentation must specify the nature of Mediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
